| 3.23 Data as of Jun 18 | +0.10 / +3.19%Today’s Change | 1.95 Today|||52-Week Range 4.50 | -7.18% Year-to-Date |
| Ovarian Cancer Drug Half Way There Jun 13 / MotleyFool.com | Amgen Drug Delays Ovarian Cancer Re-Growth, Survival Benefit Unclear Jun 12 / TheStreet.com |